Showing all 14 results
Calcium Carbonate & Vitamin D3 Tablets
FreeProduct Composition & Common Strengths
We supply this combination in standard, clinically calibrated ratios designed to optimize daily absorption thresholds without overwhelming intestinal transit.
Active Ingredient Components Standard Strengths (per Tablet) Elemental Yield / Biological Activity Primary Clinical Function Calcium Carbonate IP / BP / USP 1250 mg Yields 500 mg Elemental Calcium The Scaffold: Provides the physical structural block for bone density. Vitamin D3 (Cholecalciferol) IP/BP/USP 250 IU / 400 IU Equivalent to 6.25 mcg / 10.0 mcg The Catalyst: Chemically drives intestinal transport channels. Excipients Pharma Grade Modified Matrix Adjusters The Carrier: Ensures fast disintegration or chewable palatability. Carbimazole Tablets
FreeProduct Composition & Available Strengths
We manufacture Carbimazole in exact, internationally recognized strengths to facilitate precise dosage titration based on periodic patient blood chemistry.
Active Ingredient Standard Strengths Primary Clinical Target Carbimazole BP/IP/USP 5 mg Maintenance Titration: For long-term control once stable thyroid levels are chemically achieved. Carbimazole BP/IP/USP 10 mg Initial Suppression: High-dose intervention to rapidly bring down severely elevated $T_{3}$/$T_{4}$ levels. Clonazepam Tablets
FreeProduct Composition & Available Strengths
We supply Clonazepam across the complete, internationally standardized therapeutic spectrum to facilitate precise titration for both pediatric epilepsy and high-potency adult neurological control.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Clonazepam USP / BP / IP 0.5 mg
(500 mcg)
Oral / Sublingual Micro-Tablet Epilepsy Titration / Panic Baseline: For pediatric seizure disorders, low-dose stabilization, and initial panic management. Clonazepam USP / BP / IP 1.0 mg
(1000 mcg)
Oral / Sublingual Micro-Tablet Intermediate Maintenance: Step-up strength optimized for routine daily neurological maintenance without expanding tablet counts. Clonazepam USP / BP / IP 2.0 mg
(2000 mcg)
Oral High-Potency Solid Tablet Refractory Epilepsy & Acute Care: High-strength configuration calibrated for status epilepticus prophylaxis, myoclonic spasms, and manic stabilization. Isosorbide Tablets
FreeProduct Composition & Variants
We supply both Mononitrate and Dinitrate forms in immediate and sustained-release formats.
Variant Type Standard Strengths Primary Clinical Use Isosorbide Mononitrate 10mg, 20mg, 40mg Prophylaxis: Long-term prevention of angina. Isosorbide Dinitrate 5mg, 10mg, 20mg Acute & Chronic: Short and long-term heart failure. Sustained Release (SR) 30mg, 60mg Once-Daily: For improved patient compliance. Lamotrigine Tablets
FreeProduct Composition & Available Strengths
Because Lamotrigine demands highly delicate, low-dose introductory titration to ensure patient dermatological safety, we manufacture the full compendial strength matrix.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamotrigine USP / BP / IP 25 mg Oral Solid Uncoated / Dispersible Tablet Dermatological Intro Titration: Mandatory low-dose baseline format utilized exclusively for the critical initial 2-week dose-escalation phase. Lamotrigine USP / BP / IP 50 mg Oral Solid Uncoated / Dispersible Tablet Intermediate Step-Up Dosing: Step-up strength calibrated for weeks 3 and 4 of therapy to safely approach steady-state plasma metrics. Lamotrigine USP / BP / IP 100 mg Oral Solid Compressed Tablet Standard Maintenance Block: First-line international standard strength for adult maintenance monotherapy in epilepsy and bipolar stabilization. Lamotrigine USP / BP / IP 200 mg Oral High-Potency Solid Tablet Maximal Saturation Maintenance: High-strength configuration calibrated for advanced refractory partial seizures and combination therapies. Levofloxacin Tablets
FreeProduct Composition & Available Portfolio
We manufacture Levofloxacin across the complete, internationally standardized therapeutic spectrum to accommodate customized tissue-saturation requirements and specific treatment durations.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 250 mg Oral Solid Film-Coated Tablet Uncomplicated Infections: For standard low-dose management of uncomplicated urinary tract infections (UTIs) and acute bacterial sinusitis. Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 500 mg Oral Solid Film-Coated Tablet The Core Commercial Volume: First-line international standard for community-acquired pneumonia (CAP), skin structures, and acute pyelonephritis. Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 750 mg Oral High-Potency Solid Tablet Intensive High-Dose Short-Course: Calibrated for nosocomial pneumonia, complicated skin infections, and advanced multi-drug resistant (MDR) regimens. Levothyroxine Tablet
FreeProduct Composition & Comprehensive Portfolio Range
Because thyroid replacement demands hyper-specific, patient-tailored titrations, we manufacture the entire internationally recognized microgram ($\mu\text{g}$) matrix.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Levothyroxine Sodium USP / BP / IP 25 mcg / 50 mcg Oral Solid Uncoated Micro-Tablet Pediatric & Geriatric Initialization: For delicate low-dose titration in elderly cardiac profiles or initial pediatric replacement. Levothyroxine Sodium USP / BP / IP 75 mcg / 88 mcg / 100 mcg Oral Solid Uncoated Micro-Tablet The Core Commercial Volume: Standard adult maintenance strengths for matching routine daily baseline metabolic deficiencies. Levothyroxine Sodium USP / BP / IP 112 mcg / 125 mcg / 137 mcg Oral Solid Uncoated Micro-Tablet Precision Step-Up Adjustments: Calibrated strengths engineered to adjust plasma levels without requiring multiple or split tablets. Levothyroxine Sodium USP / BP / IP 150 mcg / 175 mcg / 200 mcg Oral High-Potency Micro-Tablet Advanced Suppression Maintenance: For severe profound hypothyroidism, total thyroidectomy recovery, and thyroid cancer suppression therapy. Loratidine Tablet
FreeProduct Composition & Available Strengths
We supply Loratadine in the internationally recognized 10 mg therapeutic dosage configuration, optimized for maximum daily compliance and clean absorption kinetics.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Loratadine USP / BP / IP 10 mg Oral Solid Immediate-Release Uncoated Tablet 24-Hour Allergy Control: Treatment of allergic rhinitis (hay fever), chronic idiopathic urticaria (hives), and ocular allergic reactions. Excipients Pharma Grade Lactose Monohydrate, Corn Starch, Magnesium Stearate The Disintegration Scaffold: Optimized matrix for high mechanical stability during bulk shipping and rapid water-wicking in the gut. Mebeverine Tablet
FreeProduct Composition & Available Formats
We supply Mebeverine Hydrochloride in both rapid-acting immediate-release and advanced continuous-release configurations to accommodate customized patient compliance tracking.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Mebeverine Hydrochloride IP / BP / USP 135 mg Oral Solid Immediate-Release Film-Coated Tablet Targeted Acute Dosing: Fast-acting formulation designed for standard three-times-daily administration prior to localized food triggers. Mebeverine Hydrochloride IP / BP / USP 200 mg SR Sustained-Release Hydrophilic Polymer Matrix Tablet / Capsule Continuous 24-Hour Coverage: Premium, once- or twice-daily formulation engineered to release active molecules continuously, eliminating nocturnal spikes and maximizing compliance. Metformin Tablet
FreeProduct Composition & Portfolio Range
We manufacture Metformin SR in the full spectrum of internationally recognized therapeutic strengths, utilizing a specialized slow-release scaffold to reduce dosing frequency to once daily.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Metformin Hydrochloride IP / BP / USP 500 mg Hydrophilic Dual-Polymer Sustained-Release Initial Titration: For low-dose introductory management and early-stage Type 2 stabilization. Metformin Hydrochloride IP / BP / USP 750 mg Hydrophilic Dual-Polymer Sustained-Release Intermediate Scaling: Step-up strength to optimize glycemic indices without increasing tablet count. Metformin Hydrochloride IP / BP / USP 1000 mg Hydrophilic Dual-Polymer Sustained-Release High-Potency Maintenance: Maximizes daily therapeutic saturation in an elegant, once-daily single tablet format. Metformin Tablets
FreeProduct Composition & Available Specifications
We supply Metformin Hydrochloride across the full spectrum of compendial strengths and advanced kinetic delivery platforms to optimize patient compliance and reduce gastrointestinal side effects.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Metformin Hydrochloride USP / BP / IP 500 mg Oral Solid Immediate-Release Film-Coated Tablet Introductory Titration: Baseline format designed for low-dose introductory management and gradual step-up scaling. Metformin Hydrochloride USP / BP / IP 850 mg Oral Solid Immediate-Release Film-Coated Tablet High-Density Single Dose: Intermediate strength optimized for achieving target daily therapeutic thresholds with fewer tablets. Metformin Hydrochloride USP / BP / IP 1000 mg Oral High-Mass Immediate-Release Tablet Maximal Saturation Therapy: High-strength configuration calibrated for advanced glycemic control and high-dose combinations. Metformin Hydrochloride USP / BP / IP 500 mg / 1000 mg SR Extended/Sustained-Release Hydrophilic Polymer Matrix Premium GI-Comfort Compliance: Once-daily formulation utilizing a dual-layer hydrogel matrix to release active drug slowly, completely eliminating gastrointestinal distress. Nifedipine Tablet
FreeProduct Composition & Structural Formats
We supply Nifedipine in exact, internationally standardized strengths, optimized for immediate-release emergency titration or controlled-release daily maintenance.
Active Ingredient Available Strengths Formulation Mechanism Primary Clinical Target Nifedipine IP / BP / USP 10 mg Immediate or Modified Release Acute Titration / Tocolysis: For rapid blood pressure adjustment or suppression of premature labor. Nifedipine IP / BP / USP 20 mg Sustained / Retard Matrix Daily Maintenance: Continuous 12-to-24-hour plasma concentration for chronic hypertension and angina. Nitroglycerin Tablet
FreeProduct Composition & Available Strengths
We supply Nitroglycerin Sublingual Tablets in exact, internationally calibrated low-dose strengths to allow for immediate rescue titration during acute ischemic episodes.
Active Ingredient Common Name Compendial Title Available Strengths Primary Clinical Target Nitroglycerin (GTN) Glyceryl Trinitrate IP / BP / USP 0.4 mg Standard Rescue Dose: Preferred international standard for immediate acute angina abortion. Nitroglycerin (GTN) Glyceryl Trinitrate IP / BP / USP 0.5 mg High-Threshold Prophylaxis: Calibrated for heavy coronary spasm management or pre-exertion protection. Ondansetron Tablet
FreeProduct Composition & Available Strengths
We supply this critical supportive therapeutic in standard, internationally recognized strengths designed for exact preventative and rescue dosing.
Active Ingredient Available Strengths Primary Clinical Target Ondansetron HCl IP / BP / USP 4 mg Standard Prophylaxis: For moderate emetogenic chemotherapy, general post-operative rescue, and pediatric care. Ondansetron HCl IP / BP / USP 8 mg High-Potency Protection: For highly emetogenic cisplatin-based cancer regimens and severe surgical recovery.
